4.8 Article

Molecular basis of mycobacterial lipid antigen presentation by CD1c and its recognition by αβ T cells

出版社

NATL ACAD SCIENCES
DOI: 10.1073/pnas.1408549111

关键词

group 1 CD1; Mycobacterium tuberculosis; T-cell reactivity

资金

  1. National Institutes of Health (NIH) [R56_AI097386, R01AI073922, R01GM102489, R01AI049313, R01AR048632]
  2. Burroughs Wellcome Fund Program in Translational Medicine
  3. NIH [HHSN272201300006C, P51 RR000165]

向作者/读者索取更多资源

CD1c is a member of the group 1 CD1 family of proteins that are specialized for lipid antigen presentation. Despite high cell surface expression of CD1c on key antigen-presenting cells and the discovery of its mycobacterial lipid antigen presentation capability, the molecular basis of CD1c recognition by T cells is unknown. Here we present a comprehensive functional and molecular analysis of alpha beta T-cell receptor (TCR) recognition of CD1c presenting mycobacterial phosphomycoketide antigens. Our structure of CD1c with the mycobacterial phosphomycoketide (PM) shows similarities to that of CD1c-mannosyl-beta 1-phosphomycoketide in that the A' pocket accommodates the mycoketide alkyl chain; however, the phosphate head-group of PM is shifted similar to 6 angstrom in relation to that of mannosyl-beta 1-PM. We also demonstrate a bona fide interaction between six human TCRs and CD1c-mycoketide complexes, measuring high to moderate affinities. The crystal structure of the DN6 TCR and mutagenic studies reveal a requirement of five complementarity determining region (CDR) loops for CD1c recognition. Furthermore, mutagenesis of CD1c reveals residues in both the beta 1 and beta 2 helices involved in TCR recognition, yet not entirely overlapping among the examined TCRs. Unlike patterns for MHC I, no archetypical binding footprint is predicted to be shared by CD1c-reactive TCRs, even when recognizing the same or similar antigens.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Immunology

Bee venom processes human skin lipids for presentation by CD1a

Elvire A. Bourgeois, Sumithra Subramaniam, Tan-Yun Cheng, Annemieke De Jong, Emilie Layre, Dalam Ly, Maryam Salimi, Annaliza Legaspi, Robert L. Modlin, Mariolina Salio, Vincenzo Cerundolo, D. Branch Moody, Graham Ogg

JOURNAL OF EXPERIMENTAL MEDICINE (2015)

Article Immunology

Molecular Analysis of Lipid-Reactive Vδ1 γδ T Cells Identified by CD1c Tetramers

Sobhan Roy, Dalam Ly, Caitlin D. Castro, Nan-Sheng Li, Andrew J. Hawk, John D. Altman, Stephen C. Meredith, Joseph A. Piccirilli, D. Branch Moody, Erin J. Adams

JOURNAL OF IMMUNOLOGY (2016)

Article Oncology

Role for High-Affinity IgE Receptor in Prognosis of Lung Adenocarcinoma Patients

Dalam Ly, Chang-Qi Zhu, Michael Cabanero, Ming-Sound Tsao, Li Zhang

CANCER IMMUNOLOGY RESEARCH (2017)

Review Immunology

Tumor-infiltrating B cells: their role and application in anti-tumor immunity in lung cancer

Si-si Wang, Wei Liu, Dalam Ly, Hao Xu, Limei Qu, Li Zhang

CELLULAR & MOLECULAR IMMUNOLOGY (2019)

Review Biochemistry & Molecular Biology

The CD1 size problem: lipid antigens, ligands, and scaffolds

Dalam Ly, D. Branch Moody

CELLULAR AND MOLECULAR LIFE SCIENCES (2014)

Article Immunology

Infusion of ex-vivo expanded human TCR-+ double-negative regulatory T cells delays onset of xenogeneic graft-versus-host disease

P. Achita, D. Dervovic, D. Ly, J. B. Lee, T. Haug, B. Joe, N. Hirano, L. Zhang

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2018)

Article Immunology

CD1c tetramers detect ex vivo T cell responses to processed phosphomycoketide antigens

Dalam Ly, Anne G. Kasmar, Tan-Yun Cheng, Annemieke de Jong, Shouxiong Huang, Sobhan Roy, Apoorva Bhatt, Ruben P. van Summeren, John D. Altman, William R. Jacobs, Erin J. Adams, Adriaan J. Minnaard, Steven A. Porcelli, Branch Moody

JOURNAL OF EXPERIMENTAL MEDICINE (2013)

Article Oncology

Human double negative T cells target lung cancer via ligand-dependent mechanisms that can be enhanced by IL-15

Junlin Yao, Dalam Ly, Dzana Dervovic, Linan Fang, Jong Bok Lee, Hyeonjeong Kang, Yu-Hui Wang, Nhu-An Pham, Hongming Pan, Ming-Sound Tsao, Li Zhang

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)

Article Oncology

Somatic Alteration Burden Involving Non-Cancer Genes Predicts Prognosis in Early-Stage Non-Small Cell Lung Cancer

Dennis Wang, Nhu-An Pham, Timothy M. Freeman, Vibha Raghavan, Roya Navab, Jonathan Chang, Chang-Qi Zhu, Dalam Ly, Jiefei Tong, Bradly G. Wouters, Melania Pintilie, Michael F. Moran, Geoffrey Liu, Frances A. Shepherd, Ming-Sound Tsao

CANCERS (2019)

Article Biology

Landscape mapping of shared antigenic epitopes and their cognate TCRs of tumor-infiltrating T lymphocytes in melanoma

Kenji Murata, Munehide Nakatsugawa, Muhammed A. Rahman, Linh T. Nguyen, Douglas G. Millar, David T. Mulder, Kenji Sugata, Hiroshi Saijo, Yukiko Matsunaga, Yuki Kagoya, Tingxi Guo, Mark Anczurowski, Chung-Hsi Wang, Brian D. Burt, Dalam Ly, Kayoko Saso, Alexandra Easson, David P. Goldstein, Michael Reedijk, Danny Ghazarian, Trevor J. Pugh, Marcus O. Butler, Tak W. Mak, Pamela S. Ohashi, Naoto Hirano

Article Hematology

CRISPR screen identifies genes that sensitize AML cells to double-negative T-cell therapy

Fraser Soares, Branson Chen, Jong Bok Lee, Musaddeque Ahmed, Dalam Ly, Enoch Tin, Hyeonjeong Kang, Yong Zeng, Nayeema Akhtar, Mark D. Minden, Housheng Hansen He, Li Zhang

Summary: AMl remains a devastating disease for which new therapies are needed. Targeted adoptive T-cell therapies have shown promise in some leukemias but not in AML. A study utilizing CRISPR/Cas9 screens identified SAGA and CD64 as key factors influencing the sensitivity of AML cells to DNT therapy.
Article Biotechnology & Applied Microbiology

Affinity-matured HLA class II dimers for robust staining of antigen-specific CD4+ T cells

Kenji Sugata, Yukiko Matsunaga, Yuki Yamashita, Munehide Nakatsugawa, Tingxi Guo, Levon Halabelian, Yota Ohashi, Kayoko Saso, Muhammed A. Rahman, Mark Anczurowski, Chung-Hsi Wang, Kenji Murata, Hiroshi Saijo, Yuki Kagoya, Dalam Ly, Brian D. Burt, Marcus O. Butler, Tak W. Mak, Naoto Hirano

Summary: By combining molecular biological and immunological techniques, this study successfully cloned sequences encoding HLA-DP, HLA-DQ, and HLA-DR molecules with enhanced CD4 binding affinity and produced affinity-matured class II dimers that stain antigen-specific T cells better than conventional multimers. These affinity-matured class II dimers will aid in the investigation of human CD4(+) T-cell responses, providing a comprehensive library of dimers for HLA-DP, HLA-DQ, and HLA-DR alleles. The readily detectable CD4(+) T cells with class II MHC dimers are crucial for studying human immune responses.

NATURE BIOTECHNOLOGY (2021)

Article Oncology

Tumor-Associated Regulatory T Cell Expression of LAIR2 Is Prognostic in Lung Adenocarcinoma

Dalam Ly, Quan Li, Roya Navab, Cedric Zeltz, Linan Fang, Michael Cabanero, Chang-Qi Zhu, Ming-Sound Tsao, Li Zhang

Summary: Understanding how the immune system regulates the tumor microenvironment is crucial for the development of effective cancer treatments. This study reveals the adverse prognostic role of LAIR2 expression in regulatory T cells and identifies it as a potential target for future immunotherapies.

CANCERS (2022)

Article Oncology

Allogeneic Human Double Negative T Cells as a Novel Immunotherapy for Acute Myeloid Leukemia and Its Underlying Mechanisms

JongBok Lee, Mark D. Minden, Weihsu C. Chen, Elena Streck, Branson Chen, Hyeonjeong Kang, Andrea Arruda, Dalam Ly, Sandy D. Der, Sohyeong Kang, Paulina Achita, Cheryl D'Souza, Yueyang Li, Richard W. Childs, John E. Dick, Li Zhang

CLINICAL CANCER RESEARCH (2018)

暂无数据